Log in to save to my catalogue

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacte...

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacte...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ec152b467db4abebb49dc8f7a4e9c3c

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections

About this item

Full title

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-10, Vol.11 (1), p.19634-18, Article 19634

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The persistent increase of multidrug-resistant (MDR)
Mycobacterium tuberculosis
(
Mtb
) infections negatively impacts Tuberculosis treatment outcomes. Host-directed therapies (HDT) pose an complementing strategy, particularly since
Mtb
is highly successful in evading host-defense by manipulating host-signaling pathways. Here, we s...

Alternative Titles

Full title

Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1ec152b467db4abebb49dc8f7a4e9c3c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ec152b467db4abebb49dc8f7a4e9c3c

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-98980-z

How to access this item